Andersons pediatric cardiology 1589

1982;104(1):115–135.
208.GottVL,CameronDE,AlejoDE,etal.Aortic
rootreplacementin271marfanpatients:a24
yearexperience.AnnThoracSurg.
2002;73(2):438–443.
209.JanuzziJL,MarayatiF,MehtaRH,etal.
Comparisonofaorticdissectioninpatientswith
andwithoutMarfan'ssyndrome(resultsfromthe
internationregistryofaorticdissection).AmJ
Cardiol.2004;94(3):400–402.
210.ElefteriadesJA.Naturalhistoryofthoracicaortic
aneurysms:indicationsforsurgery,andsurgical
versusnonsurgicalrisks.AnnThoracSurg.
2002;74(5):S1877–S1880.
211.HiratzkaLF,BakrisGL,BeckmanJA,etal.2010
ACCF/AHA/AATS/ASA/SCA/SCAI/SIR/STS/SVM
guidelinesforthediagnosisandmanagementof
patientswiththoracicaorticdisease.Circulation.
2010;121:e266–e369.
212.KallenbachK,BarakiH,KhaladiNKamiyaH,et
al.Aorticvalve-sparingoperationinMArfan
syndrome:whatdoweknowafteradecade?Ann
ThoracSurg.2007;83(2):S785–S790.
213.SettepaniF,SzetoWY,PaciniD,etal.
Reimplantationvalve-sparingaorticroot
replacementinMarfanSyndromeusingthe
valsalvaconduit:anintercontinentalmulticenter


study.AnnThoracSurg.2007;83(2):S769–S773.
214.LacroRV,DietzHC,SleeperAT,etal.Atenolol

versuslosartaninchildrenandyoungadultswith
Marfan'ssyndrome.NEngJMed.
2014;371:2061–2071.
215.GevaT,SandersSP,DiogenesMS,
RockenmacherS,VanPraaghR.Twodimensionalanddopplerechocardiographicand
pathologiccharacteristicsoftheinfantileMarfan
Syndrome.AmJCardiol.1990;65:1230–1237.
216.MorseRP,RockenmacherS,PyeritzRE,etal.
DiagnosisandmanagementofinfantileMarfan
Syndrome.Pediatrics.1990;86(6):888–895.
217.El-HabbalMH.Cardiovascularmanifestationsof
Marfan'ssyndromeintheyoung.AmHeartJ.
1992;123:752–757.
218.LoeysBL,ChenJ,NeptuneER,etal.A
syndromeofalteredcardiovascular,craniofacial,
neurocognitiveandskeletaldevelopmentcause
bymutationsinTGFBR1orTGFBR2.Nat
Genet.2005;37(3):275–281.
219.WilliamsJA,LoeysBL,NwakanmaLU,etal.
EarlysurgicalexperiencewithLoeys-dietz:a
newsyndromeofaggressivethoracicaortic
aneurysmdisease.AnnThoracSurg.
2007;83(2):S757–S763.
220.HiratzkaLF,BakrisGL,BeckmanJA,etal.2010


ACCF/AHA/AATS/ASA/SCA/SCAI/SIR/STS/SVM
guidelinesforthediagnosisandmanagementof
patientswiththoracicaorticdisease.Circulation.
2010;121:e266–e369.

221.BellamyMF,McDowellIF.Putative
mechanismsforvasculardamageby
homocysteine.JInheritMetabDis.
1997;20:307–315.
222.DudleyRW,DanialouG,GovindarajuK,etal.
Sarcolemmaldamageindystrophindeficiencyis
modulatedbysyngeristicinteractionsbetween
mechanicalandoxidative/nitrosativestresses.
AmJPathol.2006;168(4):1276–1287.
223.GlossD,MoxleyRT,AshwalS,OskouiM.
Practiceguidelineupdatesummary:
corticosteroidtreatmentofduchennemuscular
dystrophy:reportoftheguidelinedevelopment
subcommitteeoftheAmericanacademyof
neurology.Neurology.2016;86(5):465–472.
224.GulatiS,SaxenaA,KumarV,KalraV.
Duchennemusculardystrophy:prevalenceand
patternsofcardiacinvolvement.IndianJ
Pediatr.2005;72(5):389–393.
225.KirchmannC,KececiogluD,KorinthenbergR,
DittrichS.Echocardiographicand
electrocardiographicfindingsofcardiomyopathy
induchenneandBecker-kienermuscular